Darbelife 25 mcg Pfs Injection

Darbelife 25Mcg Pfs Injection

*To be consumed as directed by physician.

Therapies:

Chronic Kidney Disease

Composition:

Darbepoetin Alfa 25 mcg Pfs

About Darbelife 25Mcg Pfs Injection

Darbelife 25 mcg Pfs Injection contains Darbepoetin Alfa 25 mcg, a recombinant form of human erythropoietin designed to enhance the production of red blood cells. By stimulating erythropoiesis, it increases the differentiation of progenitor cells into red blood cells, mimicking the action of natural erythropoietin. This medication is primarily used to treat anemia caused by chronic kidney disease or chemotherapy. It works by activating the bone marrow to produce additional red blood cells, addressing the underlying deficiency.

Darbelife 25Mcg Pfs Injection

*To be consumed as directed by physician.


Usage Instructions

  • Darbelife 25mcg Pfs Injection should be administered only under the supervision of a qualified healthcare professional.
  • The dosage and frequency are determined by your doctor based on your hemoglobin levels, medical condition, and response to treatment.
  • Do not self-administer this injection.

  • Benefits and Use

    • Darbelife 25 mcg Pfs Injection effectively treats anemia caused by chronic kidney disease (CKD) and cancer chemotherapy.
    • It works by stimulating the bone marrow to produce more red blood cells, reducing symptoms like fatigue, weakness, and low energy.
    • This erythropoiesis-stimulating agent (ESA) helps maintain healthy hemoglobin levels, improving overall quality of life and well-being in patients.

    Safety Information

  • Alcohol:
  • Consult your doctor before consuming alcohol during treatment.
  • Pregnancy:
  • Use during pregnancy only if clearly prescribed by a doctor after evaluating the potential benefits and risks.
  • Breastfeeding:
  • Information regarding use during breastfeeding is limited. Consult your doctor before use.
  • Driving:
  • Darbelife 25mcg Pfs Injection generally does not affect the ability to drive or operate machinery.
  • Kidney Disease:
  • Safe for use in patients with kidney disease. No dose adjustment is generally required.
  • Liver Disease:
  • Use with caution in patients with liver disease. Consult your doctor before treatment.
  • High Blood Pressure:
  • This medicine may increase blood pressure. Regular monitoring is recommended during treatment.
  • Monitoring:
  • Regular blood tests may be required to monitor hemoglobin levels, electrolytes, and overall treatment response.

  • Ingredients

    Darbepoetin Alfa 25 mcg

    How to Use

  • Darbelife 25mcg Pfs Injection is given as an injection by a doctor or trained healthcare professional.
  • Follow your physician’s instructions carefully and attend all scheduled monitoring appointments to assess treatment response and safety.

  • Storage Information

    Store in a refrigerator (2 - 8°C). Do not freeze